Dextran sulfate suppresses cell adhesion and cell cycle progression of melanoma cells.

We have reported that dextran sulfate is a possible candidate for an antimetastatic drug because it inhibits cell adhesion. It has been demonstrated that dextran sulfate can detach cancer cells adhering to the bottom of plastic flasks, and that the detached cells do not readhere or proliferate. In this study, we investigated the effects of dextran sulfate on cancer cells, focusing on cell cycle regulators as well as cell adhesion molecules. The effects of dextran sulfate on the cell cycle were examined by flow cytometry, and changes in gene expression caused by dextran sulfate were analyzed by cDNA microarray to identify changes in adhesion and cell cycle genes. By flow cytometry, treatment with dextran sulfate increased the percentage of cells in the G1/G0-phase, and decreased those in the S- and G2/M-phases. Analysis by cDNA microarray revealed decreased expression of several genes essential for progression of the G1- and S-phases. The expression of the adhesion factors involved in metastases was also suppressed. Furthermore, we confirmed these changes in the gene expression by Northern and Western blotting. Our results indicate that dextran sulfate suppresses cell adhesion and cell cycle progression, both of which are essential for metastasis, suggesting that dextran sulfate could be used as an antimetastatic agent.

[1]  Yusuke Nakamura,et al.  Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs. , 2002, Cancer research.

[2]  T Tanaka,et al.  Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. , 2001, Cancer research.

[3]  Y. Nakamura,et al.  Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation , 2001, British Journal of Cancer.

[4]  M B Eisen,et al.  Delineating developmental and metabolic pathways in vivo by expression profiling using the RIKEN set of 18,816 full-length enriched mouse cDNA arrays , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  C. Sakakura,et al.  Dextran sulfate inhibits injured abdominal wall-specific tumor implantation in mice , 2000, Anti-cancer drugs.

[6]  M. Bittner,et al.  Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. , 2000, Cancer research.

[7]  C. Sakakura,et al.  Intraperitoneal injection of dextran sulfate as an anti-adherent drug for the prevention of peritoneal metastasis of cancer shows low toxicity in animals , 2000, Anti-cancer drugs.

[8]  Rene H Medema,et al.  Rescue of Cyclin D1 Deficiency by Knockin Cyclin E , 1999, Cell.

[9]  S. Byers,et al.  Cadherin-11 is expressed in invasive breast cancer cell lines. , 1999, Cancer research.

[10]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Sakakura,et al.  Prevention of peritoneal metastasis of cancer with dextran sulfate--an experimental study in mice. , 1997, Anti-cancer drugs.

[12]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[13]  A. Hatzigeorgiou,et al.  Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter , 1996, Molecular and cellular biology.

[14]  P. Brown,et al.  A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. , 1996, Genome research.

[15]  T. Guadagno,et al.  Cdk2 Kinase Is Required for Entry into Mitosis as a Positive Regulator of Cdc2–Cyclin B Kinase Activity , 1996, Cell.

[16]  M. Kitajima,et al.  Alteration of expression in integrin beta 1-subunit correlates with invasion and metastasis in colorectal cancer. , 1995, Cancer letters.

[17]  C. Sherr,et al.  D-type cyclins. , 1995, Trends in biochemical sciences.

[18]  K. Friedrichs,et al.  High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. , 1995, Cancer research.

[19]  S. Shurtleff,et al.  D-type cyclin-dependent kinase activity in mammalian cells , 1994, Molecular and cellular biology.

[20]  James M. Roberts,et al.  A link between cyclin A expression and adhesion-dependent cell cycle progression. , 1993, Science.

[21]  M. Mihm,et al.  Role of beta-1 integrins in organ specific adhesion of melanoma cells in vitro. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[22]  S. Reed,et al.  Association of human cyclin E with a periodic G1-S phase protein kinase. , 1992, Science.

[23]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[24]  H. Koeffler,et al.  Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. , 2001, Cancer research.

[25]  J. H. Lee,et al.  ©1999 Cancer Research Campaign Article no. bjoc.1999.0661 , 2022 .